The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: sandostatin     Quarter: 2016Q3

Total Records: 2,045     Number of Pages: 103

DRUGNAME PT EventCount
SANDOSTATIN LAR DEPOT Brain neoplasm 4
SANDOSTATIN LAR DEPOT Candida infection 4
SANDOSTATIN LAR DEPOT Cardiac failure congestive 4
SANDOSTATIN LAR DEPOT Change of bowel habit 4
SANDOSTATIN LAR DEPOT Chikungunya virus infection 4
SANDOSTATIN LAR DEPOT Conjunctival haemorrhage 4
SANDOSTATIN LAR DEPOT Conjunctival hyperaemia 4
SANDOSTATIN LAR DEPOT Decreased immune responsiveness 4
SANDOSTATIN LAR DEPOT Dermatitis allergic 4
SANDOSTATIN LAR DEPOT Diabetes insipidus 4
SANDOSTATIN LAR DEPOT Diarrhoea haemorrhagic 4
SANDOSTATIN LAR DEPOT Duodenal ulcer 4
SANDOSTATIN LAR DEPOT Endometrial cancer stage IV 4
SANDOSTATIN LAR DEPOT Endometrial thickening 4
SANDOSTATIN LAR DEPOT Eschar 4
SANDOSTATIN LAR DEPOT Eyelid oedema 4
SANDOSTATIN LAR DEPOT Face injury 4
SANDOSTATIN LAR DEPOT Facial neuralgia 4
SANDOSTATIN LAR DEPOT Fibula fracture 4
SANDOSTATIN LAR DEPOT Food poisoning 4

Total Records: 2,045     Number of Pages: 103